MyAverix Finance
V · Healthcare
Med BioGene Inc (MBI-H)
Diagnostics & Research
Med BioGene Inc (MBI-H) is listed on V in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MBI-H
Med BioGene Inc (MBI-H) — FAQ
What is MBI-H's P/E ratio?
The price-to-earnings (P/E) ratio for Med BioGene Inc (MBI-H) is 18.00 (data as of 2026-03-22).
Does Med BioGene Inc pay a dividend?
Dividend yield is not available in the current snapshot for Med BioGene Inc (MBI-H). Check the MyAverix Finance app for the latest dividend data.
What sector is Med BioGene Inc in?
Med BioGene Inc (MBI-H) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is MBI-H listed on?
MBI-H is listed on V.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.